How can neuroprotective drugs (FK506 and CsA) affect epileptogenesis and susceptibility to status epilepticus in the normal and pathological brain?

2007
journal article
review article
dc.affiliationWydział Biologii i Nauk o Ziemi : Instytut Zoologiipl
dc.contributor.authorSetkowicz-Janeczko, Zuzanna - 131836 pl
dc.date.accession2016-09-28pl
dc.date.accessioned2016-09-28T09:03:55Z
dc.date.available2016-09-28T09:03:55Z
dc.date.issued2007pl
dc.description.additionalBibliogr. s. 48-51. Zuzanna Setkowicz-Janeczko podpisana: Zuzanna Setkowiczpl
dc.description.number1pl
dc.description.physical41-51pl
dc.description.volume4pl
dc.identifier.eissn1745-1191pl
dc.identifier.issn1745-1183pl
dc.identifier.urihttp://ruj.uj.edu.pl/xmlui/handle/item/30890
dc.identifier.weblinkhttp://www.portal.uj.edu.pl/documents/27429968/27792187/Setkowicz2007b.pdfpl
dc.languageengpl
dc.language.containerengpl
dc.rightsDodaję tylko opis bibliograficzny*
dc.rights.uri*
dc.subject.enanimal models of epilepsypl
dc.subject.enbrain injurypl
dc.subject.enneuroprotectionpl
dc.subtypeReviewArticlepl
dc.titleHow can neuroprotective drugs (FK506 and CsA) affect epileptogenesis and susceptibility to status epilepticus in the normal and pathological brain?pl
dc.title.journalInternational Journal of Neuroprotection and Neuroregenerationpl
dc.typeJournalArticlepl
dspace.entity.typePublication
Affiliations

* The migration of download and view statistics prior to the date of April 8, 2024 is in progress.

Views
0
Views per month

No access

No Thumbnail Available